Recombinant CD52 (Alemtuzumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects CD52 (Alemtuzumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7487793
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD52 (Alemtuzumab Biosimilar) antibody (ABIN7487793)
Target
CD52 (Alemtuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This CD52 (Alemtuzumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Alemtuzumab Biosimilar - Anti-CD52 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD52 (Alemtuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
Campath-1H,LDP-03
Alemtuzumab is a recombinant humanized monoclonal antibody (Campath-1H), which targets the 21-28 kD cell surface glycoprotein CD52. The Campath-1H antibody is of isotype IgG1, with human variable framework and constant regions, and a complementarity determining region derived from a murine (rat) monoclonal antibody (Campath-1G). -
CAS-No
- 216503-57-0
Target
-
You are here:
